These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Homocysteine toxicity in connective tissue: theories, old and new. Toohey JI Connect Tissue Res; 2008; 49(2):57-61. PubMed ID: 18382890 [TBL] [Abstract][Full Text] [Related]
6. Chemical pathology of homocysteine. III. Cellular function and aging. McCully KS Ann Clin Lab Sci; 1994; 24(2):134-52. PubMed ID: 8203822 [TBL] [Abstract][Full Text] [Related]
7. Mercaptopropionaldehyde from homocysteine: implications for Alzheimer's disease. Toohey JI J Alzheimers Dis; 2007 Nov; 12(3):241-3. PubMed ID: 18057557 [TBL] [Abstract][Full Text] [Related]
8. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. Jakubowski H J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978 [TBL] [Abstract][Full Text] [Related]
9. Reduction of dehydroascorbic acid by homocysteine. Park JB Biochim Biophys Acta; 2001 Feb; 1525(1-2):173-9. PubMed ID: 11342267 [TBL] [Abstract][Full Text] [Related]
10. Metabolic control by dehydroascorbic acid: Questions and controversies in cancer cells. Ferrada L; Salazar K; Nualart F J Cell Physiol; 2019 Nov; 234(11):19331-19338. PubMed ID: 30963581 [TBL] [Abstract][Full Text] [Related]
11. Enzymes of creatine biosynthesis, arginine and methionine metabolism in normal and malignant cells. Bera S; Wallimann T; Ray S; Ray M FEBS J; 2008 Dec; 275(23):5899-909. PubMed ID: 19021765 [TBL] [Abstract][Full Text] [Related]
12. Antiviral effects of ascorbic and dehydroascorbic acids in vitro. Furuya A; Uozaki M; Yamasaki H; Arakawa T; Arita M; Koyama AH Int J Mol Med; 2008 Oct; 22(4):541-5. PubMed ID: 18813862 [TBL] [Abstract][Full Text] [Related]
13. Ascorbic acid in blood serum of patients with pulmonary tuberculosis and pneumonia. Bakaev VV; Duntau AP Int J Tuberc Lung Dis; 2004 Feb; 8(2):263-6. PubMed ID: 15139458 [TBL] [Abstract][Full Text] [Related]
14. Conundrum of dehydroascorbic acid and homocysteine thiolactone reaction products: Structural characterization and effect on peptide and protein N-homocysteinylation. Loubane G; Robert G; Firdaus SB; Venne P; Comeau C; Boudreault PL; Komba JE; Wagner JR; Naylor S; Klarskov K Free Radic Biol Med; 2023 Sep; 206():111-124. PubMed ID: 37385568 [TBL] [Abstract][Full Text] [Related]
15. Inhibiting effect of dehydroascorbic acid on cell division in ascites tumors in mice. Poydock ME; Reikert D; Rice J; Aleandri L Exp Cell Biol; 1982; 50(1):34-8. PubMed ID: 7060819 [TBL] [Abstract][Full Text] [Related]
16. Homocysteine pre-treatment increases redox capacity in both endothelial and tumor cells. Díaz-Santiago E; Rodríguez-Caso L; Cárdenas C; Serrano JJ; Quesada AR; Medina MÁ Redox Rep; 2017 Jul; 22(4):183-189. PubMed ID: 27198616 [TBL] [Abstract][Full Text] [Related]
17. Use of homocysteine to stabilise ascorbic acid, or to reduce dehydroascorbic acid, during HPLC separation of large volumes of tissue extracts. Bates CJ Clin Chim Acta; 1992 Feb; 205(3):249-52. PubMed ID: 1576751 [No Abstract] [Full Text] [Related]
18. Antineoplastic activity of a rhodium trichloride complex of oxalyl homocysteine thiolactone. McCully KS; Vezeridis MP Cancer Invest; 1987; 5(1):25-30. PubMed ID: 3580945 [TBL] [Abstract][Full Text] [Related]
19. The use of homocysteine in the estimation of dehydroascorbic acid. HUGHES RE Biochem J; 1956 Sep; 64(1):203-8. PubMed ID: 13363828 [No Abstract] [Full Text] [Related]
20. [Methionine dependency of cancer cells: a new therapeutic approach?]. Durando X; Thivat E; Gimbergues P; Cellarier E; Abrial C; Dib M; Tacca O; Chollet P Bull Cancer; 2008 Jan; 95(1):69-76. PubMed ID: 18230572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]